Take a moment and watch the latest webinar from Sphere Fluidics:
Accelerating Single Cell Analysis & Screening with the Power of Picodroplets
Jessica Hall, an applications specialist at Sphere Fluidics outlines the entire drug discovery lifecycle, highlighting the pivotal role of single-cell analysis. She compares traditional methods with the advanced picodroplet technology, demonstrating its advantages. Jessica also explores Cyto-Mine®, Sphere Fluidics’ innovative solution, and discusses how this technology is shaping the future of drug discovery.
Sphere Fluidics’ proprietary picodroplet microfluidic platforms are specifically designed for single-cell screening and isolation, enabling users to encapsulate and analyse single cells within a picodroplet, while maintaining viability. By harnessing this technology, Sphere Fluidics’ range of novel microfluidic tools support innovative research and accelerate biotherapeutic discovery, cell therapy, and synthetic biology workflows. To learn more contact Capella Science now on (02) 9575 7512 or sales@capellascience.com.au or Sphere Fluidics.
Recent Comments